bg
A

AN2 Therapeutics (ANTX)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About AN2 Therapeutics (ANTX)

AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The Company is focused on advancing its first product candidate, epetraborole, a once... Read more

  • USD3.23
  • USD3.38
  • USD3.22
  • USD22.22
  • 8.10%
  • --
  • 400.98k
  • 387.84k
  • 99M
  • 2.72
  • -66.70%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.